Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junko Murai

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Research Square|April 17, 2026
Ubiquitin-dependent recruitment of SLFN11 to chromatin is regulated by deubiquitinase (DUB) and RNF168Ukhyun Jo, Daiki Taniyama, Gianluca Pegoraro, et al.
Nucleic Acids Research|June 29, 2012
TDP2 promotes repair of topoisomerase I-mediated DNA damage in the absence of TDP1Zhihong Zeng, Abhishek Sharma, Limei Ju, et al.
Journal of Translational Medicine|October 4, 2017
Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancerAlberto Ballestrero, Davide Bedognetti, Domenico Ferraioli, et al.
Cancer Research|April 17, 2021
SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243Yasuhisa Murai, Ukhyun Jo, Junko Murai, et al.
Frontiers in Oncology|February 6, 2023
Schlafen family member 11 indicates favorable prognosis of patients with head and neck cancer following platinum-based chemoradiotherapySeijiro Hamada, Satoshi Kano, Junko Murai, et al.
Journal of Medicinal Chemistry|June 13, 2014
Discovery and structure-activity relationship of novel 2,3-dihydrobenzofuran-7-carboxamide and 2,3-dihydrobenzofuran-3(2H)-one-7-carboxamide derivatives as poly(ADP-ribose)polymerase-1 inhibitorsMaulik R Patel, Aaditya Bhatt, Jamin D Steffen, et al.
Molecular Cancer Therapeutics|May 12, 2018
Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I InhibitorsLaetitia Marzi, Keli Agama, Junko Murai, et al.
Expert Review of Anticancer Therapy|June 24, 2026
The dual role of Schlafen11 in brain tumors: Jekyll and HydeManabu Natsumeda, Masayasu Okada, Satoshi Nakata, et al.
Nature Medicine|March 7, 2017
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stressPeter M Bruno, Yunpeng Liu, Ga Young Park, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Ubiquitin-dependent recruitment of SLFN11 to chromatin is regulated by deubiquitinase (DUB) and RNF168Daiki Taniyama, Gianluca Pegoraro, Ying Wu, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Research Square|April 17, 2026
Ubiquitin-dependent recruitment of SLFN11 to chromatin is regulated by deubiquitinase (DUB) and RNF168Ukhyun Jo, Daiki Taniyama, Gianluca Pegoraro, et al.
Nucleic Acids Research|June 29, 2012
TDP2 promotes repair of topoisomerase I-mediated DNA damage in the absence of TDP1Zhihong Zeng, Abhishek Sharma, Limei Ju, et al.
Journal of Translational Medicine|October 4, 2017
Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancerAlberto Ballestrero, Davide Bedognetti, Domenico Ferraioli, et al.
Cancer Research|April 17, 2021
SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243Yasuhisa Murai, Ukhyun Jo, Junko Murai, et al.
Frontiers in Oncology|February 6, 2023
Schlafen family member 11 indicates favorable prognosis of patients with head and neck cancer following platinum-based chemoradiotherapySeijiro Hamada, Satoshi Kano, Junko Murai, et al.
Journal of Medicinal Chemistry|June 13, 2014
Discovery and structure-activity relationship of novel 2,3-dihydrobenzofuran-7-carboxamide and 2,3-dihydrobenzofuran-3(2H)-one-7-carboxamide derivatives as poly(ADP-ribose)polymerase-1 inhibitorsMaulik R Patel, Aaditya Bhatt, Jamin D Steffen, et al.
Molecular Cancer Therapeutics|May 12, 2018
Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I InhibitorsLaetitia Marzi, Keli Agama, Junko Murai, et al.
Expert Review of Anticancer Therapy|June 24, 2026
The dual role of Schlafen11 in brain tumors: Jekyll and HydeManabu Natsumeda, Masayasu Okada, Satoshi Nakata, et al.
Nature Medicine|March 7, 2017
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stressPeter M Bruno, Yunpeng Liu, Ga Young Park, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Ubiquitin-dependent recruitment of SLFN11 to chromatin is regulated by deubiquitinase (DUB) and RNF168Daiki Taniyama, Gianluca Pegoraro, Ying Wu, et al.
Pageof 8